PENTAGLOBIN

This brand name is authorized in Austria, Brazil, Ecuador, Hong Kong, Poland, Singapore, Turkey, South Africa

Active ingredients

The drug PENTAGLOBIN contains one active pharmaceutical ingredient (API):

1 Human plasma protein of which human immunoglobulin at least 95% UNII 6D53G0FD0Z - PLASMA PROTEIN FRACTION (HUMAN)

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. Read about Immunoglobulins, normal human, IV

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06B	Immunoglobulins	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins
Discover more medicines within J06B
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 524616020001904, 524616020002004, 524619120002807
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 160-MBE-0720, 20.366-1-08-04
Country: HK	Department of Health Drug Office	Identifier(s): 43941
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100195638
Country: SG	Health Sciences Authority	Identifier(s): 11205P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699535980417
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/30.2/0007, 28/30.2/0008, 28/30.2/0009